| Carlos J Vives Alvarado, MD | |
|
Ave. De Diego 369, Torre San Francisco Suite 310, Rio Piedras, PR 00923 | |
| (787) 767-8872 | |
| Not Available |
| Full Name | Carlos J Vives Alvarado |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 9 Years |
| Location | Ave. De Diego 369, Rio Piedras, Puerto Rico |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902207459 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 21279 (Puerto Rico) | Secondary |
| 207W00000X | Ophthalmology | 21279 (Puerto Rico) | Primary |
| Entity Name | Glaucoma Specialists Of Puerto Rico, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104587757 PECOS PAC ID: 5193118396 Enrollment ID: O20220211000363 |
News Archive
IDEV Technologies, Incorporated, an emerging leader in the development and commercialization of minimally invasive medical technologies, today announced that it has completed a $46 million Series D round of financing, with Piper Jaffray & Co.'s Merchant Banking Fund and a leading strategic global healthcare company as the two new investors.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
The U.S. Census Bureau will hold an online news conference to announce the findings from its annual report: Income, Poverty, and Health Insurance Coverage in the United States: 2008. This report contains the official national findings from the Current Population Survey (CPS).
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
The National Institute for Health and Clinical Excellence has published a new guideline which should help to improve care for thousands of patients with advanced cancer that has spread from an unknown primary location.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Carlos J Vives Alvarado, MD Urb Los Paseos, 1 Paseo Sereno, San Juan, PR 00926 Ph: (787) 485-3480 | Carlos J Vives Alvarado, MD Ave. De Diego 369, Torre San Francisco Suite 310, Rio Piedras, PR 00923 Ph: (787) 767-8872 |
News Archive
IDEV Technologies, Incorporated, an emerging leader in the development and commercialization of minimally invasive medical technologies, today announced that it has completed a $46 million Series D round of financing, with Piper Jaffray & Co.'s Merchant Banking Fund and a leading strategic global healthcare company as the two new investors.
ClaimRemedi, a provider of claim lifecycle management solutions, announced recently that they have signed an agreement with HealthPac Computer Systems, Inc., a Savannah, GA based Practice Management and Medical Billing software company. Under the agreement, ClaimRemedi will provide a complete end-to-end revenue cycle management solution for HealthPac customers.
The U.S. Census Bureau will hold an online news conference to announce the findings from its annual report: Income, Poverty, and Health Insurance Coverage in the United States: 2008. This report contains the official national findings from the Current Population Survey (CPS).
Oxis Biotech, Inc., a wholly owned subsidiary of Oxis International, Inc., announced today the execution of an exclusive worldwide license agreement to further develop and commercialize DT2219ARL, a novel therapy for the treatment of various human B cell cancers, leukemias and lymphomas.
The National Institute for Health and Clinical Excellence has published a new guideline which should help to improve care for thousands of patients with advanced cancer that has spread from an unknown primary location.
› Verified 2 days ago
Dr. Armando L Oliver, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 369 De Diego Avenue, Torre San Francisco Suite 310, Rio Piedras, PR 00923 Phone: 787-767-9030 | |
Dr. Yaris Arlene Leon Figueroa, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Carr. 21 U3 #2, Las Lomas, Rio Piedras, PR 00921 Phone: 787-781-9540 Fax: 787-782-5890 | |
Dr. Francisco J Monserrate Rodriguez, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 369 Ave De Diego, Torre San Francisco 608, Rio Piedras, PR 00923 Phone: 787-302-2020 Fax: 787-756-6378 | |
Dr. Raul Perez, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: Clinica De La Escuela De Medicina, Reparto Metropolitano Shopping, Rio Piedras, PR 00921 Phone: 787-758-7910 Fax: 787-625-1966 | |
Guillermo Velasquez-velez, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: Clinica De La Escuela De Medicina, Reparto Metropolitano Shopping Ave. Americo Miranda, Rio Piedras, PR 00921 Phone: 787-758-7910 Fax: 787-758-3488 | |
Dr. Diana P Martinez, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 112 Calle Arzuaga, Suite 802, Rio Piedras, PR 00925 Phone: 787-767-6915 Fax: 787-765-4140 |